Robert Gagnon, CFO at Harvard Bioscience, holds 27.39K shares in Verastem (Ticker: VSTM), holds 321.17K shares in Harvard Bioscience (Ticker: HBIO), holds ― shares in Bone Biologics (Ticker: BBLG). Most recently, Robert Gagnon Sold ― shares of Verastem on Mar 20, 2024 for an estimated value of 4.38K.